Sulindac and erlotinib for familial adenomatous polyposis - Reply

Niloy Jewel Samadder, Deborah W. Neklason, Randall W. Burt

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Number of pages1
JournalJAMA - Journal of the American Medical Association
Volume316
Issue number5
DOIs
StatePublished - Aug 2 2016
Externally publishedYes

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Duodenal Neoplasms
Sulindac
Adenomatous Polyposis Coli
Antineoplastic Agents
Erlotinib Hydrochloride

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sulindac and erlotinib for familial adenomatous polyposis - Reply. / Samadder, Niloy Jewel; Neklason, Deborah W.; Burt, Randall W.

In: JAMA - Journal of the American Medical Association, Vol. 316, No. 5, 02.08.2016.

Research output: Contribution to journalLetter

@article{643e1a69914b4ae0848c8ebe71e46ecc,
title = "Sulindac and erlotinib for familial adenomatous polyposis - Reply",
author = "Samadder, {Niloy Jewel} and Neklason, {Deborah W.} and Burt, {Randall W.}",
year = "2016",
month = "8",
day = "2",
doi = "10.1001/jama.2016.7595",
language = "English (US)",
volume = "316",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Sulindac and erlotinib for familial adenomatous polyposis - Reply

AU - Samadder, Niloy Jewel

AU - Neklason, Deborah W.

AU - Burt, Randall W.

PY - 2016/8/2

Y1 - 2016/8/2

UR - http://www.scopus.com/inward/record.url?scp=84982174901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982174901&partnerID=8YFLogxK

U2 - 10.1001/jama.2016.7595

DO - 10.1001/jama.2016.7595

M3 - Letter

C2 - 27483082

AN - SCOPUS:84982174901

VL - 316

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 5

ER -